How to manage patients with moderate-risk germline mutations.

How to manage patients with moderate-risk germline mutations. Clin Adv Hematol Oncol. 2018 Feb;16(2):97-101 Authors: Tung NM PMID: 29741508 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29741508?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - May 11, 2018 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research

More News: Cancer & Oncology | Hematology